RecombinantMycobacterium bovisBCG Producing the N-Terminal Half of SIVmac251 Env Antigen Induces Neutralizing Antibodies and Cytotoxic T Lymphocyte Responses in Mice and Guinea Pigs-Reference-Cited by-同舟云学术

RecombinantMycobacterium bovisBCG Producing the N-Terminal Half of SIVmac251 Env Antigen Induces Neutralizing Antibodies and Cytotoxic T Lymphocyte Responses in Mice and Guinea Pigs

Published:1997-12-10 Issue:18 Volume:13 Page:1573-1581
ISSN:0889-2229
Container-title:AIDS Research and Human Retroviruses
language:en
Short-container-title:AIDS Research and Human Retroviruses

Author:

LIM ENG MONG,LAGRANDERIE MICHELINE,LE GRAND ROGER,RAUZIER JEAN,GHEORGHIU MARINA,GICQUEL BRIGITTE,WINTER NATHALIE

Publisher

Mary Ann Liebert Inc

Subject

Infectious Diseases,Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/aid.1997.13.1573

Reference38 articles.

1. Mycobacterial diseases

2. Introduction of foreign DNA into mycobacteria using a shuttle phasmid

3. New use of BCG for recombinant vaccines

4. Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.

5. Protective humoral response against pneumococcal infection in mice elicited by recombinant bacille Calmette-Guérin vaccines expressing pneumococcal surface protein A.

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mycobacterium tuberculosis disease associates with higher HIV-1-specific antibody responses;iScience;2023-05

2. Mycobacterium tuberculosisdisease associates with higher HIV-1-specific antibody responses;2022-12-02

3. Recombinant Bacillus Calmette-Guérin for Mucosal Immunity;Mucosal Vaccines;2020

4. Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned;Expert Review of Vaccines;2018-11-02

5. Development of novel plant-based adjuvant formulation against rubella and hepatitis B vaccine antigen;Herba Polonica;2016-09-01